Trial ID or NCT#

NCT03270722

Status

RECRUITING

Purpose

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Official Title

Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma

Eligibility Criteria

Ages Eligible for Study: 18 Years to 90 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Nielsen Fernandez-Becker
Gastroenterologist, Celiac disease specialist, Motility specialist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Lorinda Chung
Rheumatologist, Immunologist
Professor of Medicine (Immunology and Rheumatology) at the Palo Alto Veterans Affairs Health Care Center
John Clarke
Gastroenterologist, Motility specialist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

Contact us to find out if this trial is right for you.

CONTACT

John O Clarke, MD
(650) 736-5555